CPA
GH icon

Capital Performance Advisors’s Guardant Health GH Stock Holding History

Capital Performance Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$46 – 1136
2024
Q3 		$46 Buy
+2
New +$57 ﹤0.01% 2798

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Capital Performance Advisors's GH Position: Q4 2024 in Review

Capital Performance Advisors sold out of Guardant Health (GH) in Q4 2024, closing a stake of 2 shares — an estimated $46 sold.

Capital Performance Advisors first reported a position in GH in Q3 2024 and held it in 1 quarter. The position peaked at $46 in Q3 2024. 297 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Capital Performance Advisors reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 2 Guardant Health shares in Q4 2024, an estimated $46.
  • Capital Performance Advisors first reported a position in Guardant Health in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Guardant Health position peaked at $46 in Q3 2024.
  • 297 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.